# Samara Capital

> Samara Capital is a VC fund in Mumbai backing Health Care and Medical. See 5 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Mumbai, India
- Total investments: 5
- Last investment: Oct 2021
- Lead investor: 40%
- Last updated: Aug 2026
- Website: http://samaracapital.com

Samara Capital is an entrepreneurially run India focused private equity firm. Samara invests in Emerging Indian Companies (EICs) – which it defines as those businesses that are poised for rapid transformation due to a strong entrepreneurial minded management team and a favorable external context.Being an entrepreneurial firm itself, Samaravalues and understands the importance of relationship comfort, freedom, trust, nimbleness and flexibility, which is what it seeks from and gives to its partner entrepreneurs.

## Contacts

5 contacts available for Samara Capital. Shizune tracks 4 team members at Samara Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/samara-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 60% |
| Medical | 2 | 40% |
| Medical Device | 2 | 40% |
| Banking | 1 | 20% |
| FinTech | 1 | 20% |

13 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Private Equity | 2 | 40% |
| Pre-Seed | 1 | 20% |
| Series C | 1 | 20% |
| Funding Round | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| India | 4 | 80% |
| United States | 1 | 20% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Anchit Gupta | Managing Director | 1 | — |
| Gautam Gode | Co-Founder & Managing Director | 0 | — |
| Sumeet Narang | Founder and Managing Director | 0 | — |
| Vikram Agarwal | Director and Chief Financial Officer | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Marengo Asia Healthcare | Marengo Asia Healthcare is a platform that will run multispecialty hospital chains formed by Samara Capital, Havells Family Investment Office, and Godrej Family Investment Office. |  | Pre-Seed | Oct 28, 2021 |  |
| Terns Pharmaceuticals | Terns Pharmaceuticals develops small-molecule therapies for chronic diseases including cancer, metabolic disorders, and liver conditions. The company designs drug candidates that target specific biological pathways involved in disease progression, using medicinal chemistry and translational science approaches. Its pipeline includes programs aimedat cancers with defined genetic drivers as well as treatments for conditions like nonalcoholic steatohepatitis and obesity. Terns Pharmaceuticals conducts preclinical research and clinical trials to evaluate safety, efficacy, and dosing of its compounds. The organization collaborates with research partners and contract organizations to support development, regulatory processes, and data generation. | $87M | Series C | Jan 05, 2021 |  |
| Sahajanand Medical Technologies | A leading developer and manufacturer of minimally invasive coronary stent systems, with one of the broadest product portfolios in the industry. they have a strong international presence with footprints in more than 40 countries. SMT believe in continuous innovation and up-gradation of our portfolio in order to cater your healthcare needs. Theircommitment is to advance the patient care by introducing state of the art medical devices which will enable us to save precious lives. They are committed to the welfare of all the patients around the world. Their portfolio includes drug eluting stents, bare metal stents, balloon catheters and inflation devices. Their aim is to expand our portfolio which will comprehensively cover all facets of cardiovascular treatment support. | $27.4M | Private Equity | Jan 10, 2018 |  |
| RBL Bank | RBL Bank is a private-sector bank that offers personal, preferred, business, and wholesale banking services. It is continuously expanding its presence across India through a growing network of branches and ATMs.Established in 1943, RBL Bank undertook a transformational journey under a new management team in 2010. RBL Bank embarked on anaggressive growth plan based on a robust platform of strong governance, relationships, technology infrastructure, high-quality capital, and geographic expansion. Over the last two years, it has infused capital of over र 1,100 Crore from some of the most notable global and domestic names, taking the TIER 1 capital to र 1,600 Crore (approx.)Today, RBL Bank offers specialized services under the five business verticals: namely Corporate & Institutional Banking, Commercial Banking, Retail Banking, Agri & Development Banking, and Financial Markets. The bank currently services over 5 Lakh customers and has a total business size of over Rs. 14,500 Crore. | $1.9M |  | Feb 11, 2011 |  |
| Thyrocare Technologies | Thyrocare Technologies Limited is India's first fully automated diagnostic laboratory with a focus on providing quality reports at affordable costs to laboratories and hospitals in India and other countries.Thyrocare operates this unique centralised laboratory model with the focus on strong technologies, strong brands and strong systemsthat enable all laboratories to give their clients the best of science and technology at affordable costs. |  | Private Equity |  |  |

5 of 5 investments shown.

## Co-investors
- [Beacon India Private Equity Fund](https://shizune.co/investors/profile/beacon-india-private-equity-fund) — VC Fund, 1 deal together
- Cartica — VC Fund, 1 deal together
- CX Partners — VC Fund, 1 deal together
- [Deerfield](https://shizune.co/investors/profile/deerfield) — VC Fund, 1 deal together
- [Deerfield Management](https://shizune.co/investors/profile/deerfield-management-83d0) — VC Fund, 1 deal together
- [Eli Lilly](https://shizune.co/investors/profile/eli-lilly) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Foresight Group](https://shizune.co/investors/profile/foresight-group) — VC Fund
- [YFM Equity Partners](https://shizune.co/investors/profile/yfm-equity-partners) — VC Fund
- [Fondaction](https://shizune.co/investors/profile/fondaction) — VC Fund

## FAQ

### What does Samara Capital invest in?

Samara Capital invests primarily in Health Care, Medical and Medical Device startups, most often at Private Equity and Pre-Seed stage. Most of the 5 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Samara Capital?

Public channels for Samara Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Samara Capital?

The team at Samara Capital includes Anchit Gupta (Managing Director), Gautam Gode (Co-Founder & Managing Director) and Sumeet Narang (Founder and Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co